Evidence map›Paper›PMID 29949619›Full record

ArticlePloS one2018

Central precocious puberty in Boston boys: A 10-year single center experience.

Lisa Swartz Topor, Kimberly Bowerman, Jason T Machan, Courtney L Gilbert, Tairmae Kangarloo, Natalie D Shaw

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Central Precocious Puberty in Italian Boys: Data From a Large Nationwide Cohort.The Journal of clinical endocrinology and metabolism · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 1 country.

Lisa Swartz ToporDepartment of Pediatrics, Division of Pediatric Endocrinology, Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.ORCID 0000-0002-1219-9921
Kimberly BowermanAlpert Medical School of Brown University, Providence, Rhode Island, United States of America.
Jason T MachanAlpert Medical School of Brown University, Providence, Rhode Island, United States of America.
Courtney L GilbertUniversity of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Tairmae KangarlooReproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Natalie D ShawReproductive Endocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Brown University · USMassachusetts General Hospital · USNational Institutes of Health · USProvidence College · USUniversity of Massachusetts Chan Medical School · USUniversity of Rhode Island · US

Funding

Harvard Clinical and Translational Science CenterUL1TR001102 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$106.2M
Investigating the impact of obesity on pubertal development in girlsZIAES103315 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI SHAW, NATALIE · 2016 to 2025
$5.9M
NCATS NIH HHS UL1 TR001102NIEHS NIH HHS ZIA ES103315
6 · The paper itself

Abstract

objectiveRecent studies in the US and abroad suggest that boys are undergoing puberty at a younger age. It is unknown if this secular trend extends to boys with central precocious puberty (CPP), who sit at the extreme end of the pubertal spectrum, and if neuroimaging should remain a standard diagnostic tool. STUDY

designRetrospective chart review of all boys with CPP seen by Endocrinology at a US pediatric hospital from 2001-2010.

resultsFifty boys had pubertal onset at an average age of 7.31 years (95CI 6.83-7.89), though many did not present until nearly one year thereafter, by which time 30% were mid-to-late pubertal. Boys were predominantly non-Hispanic White and 64% were overweight/obese. The majority (64%) of boys had neurogenic CPP (CNS-CPP) with neurofibromatosis type I being the most common diagnosis. Diagnosis of CPP led to discovery of a neurogenic lesion in only 3 of 32 (9%) CNS-CPP cases. The remaining boys, with idiopathic CPP (36%), were indistinguishable from those with CNS-CPP aside from four boys who endorsed a family history of PP (22% vs. 0% among CNS-CPP cases). Importantly, there was no change in the incidence of male CPP after accounting for the increase in clinic volume during this time period.

conclusionIn this contemporary Boston-based cohort of 50 boys with CPP, most cases were neurogenic, consistent with older literature. Several idiopathic cases had a family history of PP but were otherwise indistinguishable from CNS-CPP cases. Thus, neuroimaging remains a critical diagnostic tool. We find no evidence for an increase in the prevalence of male CPP.

Indexed as

BostonChildFollicle Stimulating HormoneHumansLuteinizing HormoneMalePuberty, PrecociousRetrospective StudiesTestosteroneFollicle Stimulating HormoneLuteinizing HormoneTestosterone

Identifiers

PMID29949619
PMCPMC6021063
OpenAlexW2811315318

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.